ERBB2 and cancer: It is of note that in the ASCO/CAP guidelines, group 2 cancers (HER2/Cep17 ratio ≥ 2, HER2 copy number < 4) are generally categorised as HER2-negative (HER2-low) [2] but are regarded as HER2-positive in the UK guidelines [1].